Newcastle's Freeman Hospital and Northern Centre for Cancer Care manage significant myeloma patient populations requiring Lenalidomide-based therapy. Following patent expiry, Lenalid 25mg provides dramatic cost savings without compromising the clinical outcomes that have made Lenalidomide a cornerstone of myeloma treatment.
The Rd (Revlimid-dexamethasone) combination has become a standard treatment backbone for myeloma patients at all stages, and Newcastle's haematology unit uses it for both induction and maintenance settings. Generic Lenalid provides the same evidence-based treatment at significantly lower cost.
Visit medshopy.com or WhatsApp +91 82650 41513 for supply details.
The Rd (Revlimid-dexamethasone) combination has become a standard treatment backbone for myeloma patients at all stages, and Newcastle's haematology unit uses it for both induction and maintenance settings. Generic Lenalid provides the same evidence-based treatment at significantly lower cost.
Visit medshopy.com or WhatsApp +91 82650 41513 for supply details.